Chat with us
Research Assistance
Online
  • Please enter your first name.

Japan Veterinary Oncology Market Size & Outlook, 2026-2033

The veterinary oncology market in Japan is expected to reach a projected revenue of US$ 166.2 million by 2033. A compound annual growth rate of 10.6% is expected of Japan veterinary oncology market from 2026 to 2033.

  • Animal Health
    • Veterinary Services & IT
      • Veterinary Oncology Market Outlook
Revenue, 2025 (US$M)
$72.5
Estimate, 2026 (US$M)
$82.0
Forecast, 2033 (US$M)
$166.2
CAGR, 2026 - 2033
10.6%

Japan Veterinary Oncology Market, 2021-2033 (US$M)

Japan Veterinary Oncology Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the veterinary oncology market

Every figure cited from GVR research

Japan veterinary oncology market outlook highlights

The Japan veterinary oncology market outlook generated a revenue of USD 72.5 million in 2025 and is expected to reach USD 166.2 million by 2033.
  • The market is expected to grow at a CAGR of 10.6% from 2026 to 2033.
  • In terms of segment, canine was the largest revenue generating animal type in 2025.
  • Canine is the most lucrative animal type segment registering the fastest growth during the forecast period.

  • Veterinary Oncology Market Outlook data book summary

    Market revenue in 2025USD 72.5 million
    Market revenue in 2033USD 166.2 million
    Growth rate10.6% (CAGR from 2026 to 2033)
    Largest segmentCanine
    Fastest growing segmentCanine
    Historical data2021 - 2024
    Base year2025
    Forecast period2026 - 2033
    Quantitative unitsRevenue in USD million
    Market segmentationCanine, Feline, Equine
    Key market players worldwideZoetis Inc Class A, Karyopharm Therapeutics Inc, Varian, Accuray Inc, Petcure Oncology, Boehringer Ingelheim, Elanco Animal Health Inc, One Health Group, Regeneus

    Other key industry trends

      In terms of revenue, Japan accounted for 4.1% of the veterinary oncology market outlook in 2025.
    • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
    • In Asia Pacific, China veterinary oncology market outlook is projected to lead the regional market in terms of revenue in 2033.
    • Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 130.6 million by 2033.

    No credit card required*

    Publish Date: Nov 02, 2026

    Customize the Report

    20% free customization

    Include
    Countries, segments, points
    Tailor
    To your product definition
    Extend
    Deeper competitor detail
    Or
    A fully bespoke study

    Horizon in a snapshot

    • 30K+ Global Market Reports
    • 120K+ Country Reports
    • 1.2M+ Market Statistics
    • 200K+ Company Profiles
    • Industry insights and more

    Veterinary Oncology Market Companies

    NameProfile# EmployeesHQWebsite
    Zoetis Inc Class AView profile 14,10010 Sylvan Way, Parsippany, NJ, United States, 07054www.zoetis.com
    Elanco Animal Health IncView profile 9,8002500 Innovation Way, Greenfield, IN, United States, 46140www.elanco.com
    Boehringer IngelheimView profile 10001+Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europewww.boehringer-ingelheim.com/
    Accuray IncView profile 1,0241240 Deming Way, Madison, WI, United States, 53717www.accuray.com
    VarianView profile 5001-10000Palo Alto, California, United States, North Americawww.varian.com/
    Karyopharm Therapeutics IncView profile 32585 Wells Avenue, 2nd Floor, Newton, MA, United States, 02459www.karyopharm.com
    PetCure OncologyView profile 11-50Deerfield, Illinois, United States, North Americapetcureoncology.com/
    One Health GroupView profile 1-10Cazenovia, New York, United States, North Americawww.onehealthgroup.com/
    RegeneusView profile 11-50Pymble, New South Wales, Australia, Oceaniaregeneus.com.au/

    Japan Veterinary Oncology Market Outlook

    The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Oncology Market Outlook will help companies and investors design strategic landscapes.


    Canine was the largest segment with a revenue share of 96.19% in 2025.

    Horizon Databook has segmented the Japan veterinary oncology market based on canine, feline, equine covering the revenue growth of each sub-segment from 2021 to 2033.


    • Japan Veterinary Oncology Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
      • Canine
      • Feline
      • Equine
    • Japan Veterinary Oncology Market Therapy Outlook (Revenue, USD Million , 2021-2033)
      • Radiotherapy
      • Surgery
      • Chemotherapy
      • Immunotherapy
      • Other
    • Japan Veterinary Oncology Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
      • Skin Cancers
      • Lymphomas
      • Sarcomas
      • Others

    Reasons to subscribe to Veterinary Oncology Market Outlook databook

    • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
    • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
    • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
    • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
    • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

    Target buyers of Veterinary Oncology Market Outlook databook

    • Our clientele includes a mix of Veterinary Oncology Market Outlook companies, investment firms, advisory firms & academic institutions.
    • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
    • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
    • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

    Horizon Databook provides a detailed overview of country-level data and insights on the Japan Veterinary Oncology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Veterinary Oncology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

    Japan Veterinary Oncology Market, 2021-2033 (US$M)

    No Access Stack Chart

    Japan veterinary oncology market statistics, by animal type 2021 - 2033 (US$M)

    No Access Pie Chart

    Japan veterinary oncology market statistics, by animal type 2021 - 2033 (USD Million)

    No Access

    Sign up - it's easy, and free!

    Sign up and get instant basic access to databook, upgrade
    when ready, or enjoy our free plan indefinitely.

    Included in Horizon account

    • 30K+ Global Market Reports
    • 120K+ Country Reports
    • 1.2M+ Market Statistics
    • 200K+ Company Profiles
    • Industry insights and more